Nov 5 (Reuters)-
Zeria Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2025 Sep 30, 2024 Mar 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 39.96 42.42 90.00
(-5.8 pct) (+15.7 pct) (+3.1 pct)
Operating 3.64 6.46 12.00
(-43.6 pct) (+21.2 pct) (-1.6 pct)
Recurring 2.66 7.95 12.00
(-66.6 pct) (+44.6 pct) (-6.5 pct)
Net 1.74 6.06 9.50
(-71.3 pct) (+12.3 pct) (-4.4 pct)
EPS 39.42 yen 137.51 yen 215.52 yen
Ann Div 47.00 yen 48.00 yen
-Q2 div 24.00 yen 23.00 yen
-Q4 div 24.00 yen 24.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T